m+Medelevator.RU
← Поиск публикаций
BMC medical imaging · 2026

A deep learning algorithm for coronary heart disease prediction based on retinal fundus photographs and optical coherence tomography.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Yan Ran, Guo Xiaoxiao, Zhu Jiang, Zhu Yan, Hong Tingting, Zhang Weijie, Ma Zongqing, Gao Xinxiao

Аннотация

BACKGROUND: Coronary heart disease (CHD) is a major cause of mortality worldwide. This study aimed to develop and validate a multimodal deep learning algorithm using retinal imaging to assist in CHD risk assessment.

METHODS: In this retrospective study, we developed a deep learning algorithm that integrates retinal fundus photographs and optical coherence tomography (OCT) images. A clinical nomogram was also developed by combining the imaging-based predictions with clinical risk factors. Model performance was evaluated on internal validation and test cohort using receiver operating characteristic (ROC) analysis and calibration curves.

RESULTS: The algorithm was developed and validated using a dataset of 505 patients, which included 282 with CHD. On the training cohort, the model achieved an area under the curve (AUC) of 0.9954 (95% CI: 0.9904-1.0000). On the independent validation and test cohorts, the model achieved AUCs of 0.9834 (95% CI: 0.9556-1.0000) and 0.9138 (95% CI: 0.8404-0.9871), respectively. The nomogram demonstrated an AUC of 0.9963 (95% CI, 0.9923-1.0000) on the training cohort, and AUCs of 0.9423 (95% CI, 0.8626-1.0000) and 0.9153 (95% CI, 0.8289-1.0000) on the internal validation and test cohort, respectively.

CONCLUSIONS: This study demonstrates the feasibility of using a deep learning algorithm based on retinal imaging for CHD risk stratification. Future prospective, multicenter studies are needed to validate these findings and evaluate their potential clinical utility.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты